ISSN 1662-4009 (online)

ey0016.3-14 | Graves’ Disease | ESPEYB16

3.14. Long-term methimazole therapy in juvenile Graves' disease: a randomized trial

F Azizi , M Takyar , E Madreseh , A Amouzegar

To read the full abstract: Pediatrics. 2019;143(5).This randomized prospective long-term study investigated the effect of long-term (8–10 years) versus short-term (18–24 months) methimazole therapy for Graves’ disease in 56 Iranian adolescents. The primary endpoint was disease remission at 48 months after stopping methimazole.The authors obs...